New Delhi: Takeda Biopharmaceuticals India Pvt Ltd on Monday, July 20, said it has received market authorisation from the Drug Controller General of India (DCGI) for dengue prevention vaccine, QDENGA. QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It can be administered regardless … Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
LIVE
--
--
--
--
--
--
--
--
Global Weather
Loading...
Fetching latest reports
--°C
